In this study, we emphasize to investigate whether polymorphisms of 7 MMR genes (MLH1, MSH2, MSH3, MSH4, MSH5, MSH6 and SAPCD1) were related to the prognosis of platinum-based chemotherapy in 346 lung cancer patients. The gene discussed is MSH6; the disease is lung carcinoma.